AIRSNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Airsculpt Technologies, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$1.25−0.03 (-2.35%)
Close on Oct 19, 2026
- Market cap
- $88.13M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$7.87 (−86.35%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Airsculpt Technologies, Inc. saw revenue fall 8.7% to $150.72M over the twelve months to Jun 30, 2026. Free cash flow was $760.00K.
Revenue
$150.72M
-8.7% vs. a year earlier
Operating income
-$12.59M
TTM Q2 2026
Free cash flow
$760.00K
TTM Q2 2026
EPS, diluted
-$0.18
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $88.13M
- P/E ratio
- –
- Price to sales
- 0.58
- Price to book
- 0.84
- Dividend yield
- –
- Free cash flow yield
- 0.86%
Fundamentals
- Revenue
- $150.72M
- Net income
- -$11.74M
- EPS, diluted
- -$0.18
- Free cash flow
- $760.00K
- Book value per share
- $1.48
- Diluted shares
- 71M
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Revenue
$150.72M-8.7% YoY
Gross profit
$90.03M-7.8% YoY
Operating income
-$12.59M
Net income
-$11.74M
EPS, diluted
-$0.18
Free cash flow
$760.00K
Reported periodTrailing twelve months